Genome-Based Analysis of Mutations Driving Ciprofloxacin Resistance in Klebsiella pneumoniae
Abstract
Klebsiella pneumoniae functions as a major pathogenic microorganism that causes pneumonia infections, urinary tract infections, and bloodstream infections. The advanced resistance of K. pneumoniae against ciprofloxacin presents medical professionals with significant management issues for treatment strategies. This research examined ciprofloxacin resistance-related genetic mutations and alterations in K. pneumoniae through detailed analysis of essential DNA gyrase and topoisomerase IV genes: gyrA, gyrB, parC, and parE. The research analysed alterations between resistant and susceptible microbial strains through bioinformatics methodology. The scientific confirmation established that ciprofloxacin resistance exhibits a strong relationship with gyrA mutations at Ser83, along with Asp87 positions. Research confirms that enzyme structure changes caused by these alterations lead to decreased ciprofloxacin binding effectiveness. The mutation of Ser359Ala and Ser367Thr in gyrB increased bacterial resistance slightly when compared to gyrA mutations. Ser80Ile and Glu84Val parC mutations showed a reduction in ciprofloxacin binding ability, thus causing an increase in resistance. The drug-binding site of ciprofloxacin became stronger through parE mutations that included Ile529Leu and Ser458Ala, which reinforced ciprofloxacin resistance. Genomic surveillance must remain active because these research results verify the contribution of these mutations to ciprofloxacin resistance. Research…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.